← Eichor
Condition: Left Sided Colorectal Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Left Sided Colorectal Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
Phase 3 · 1 location(s) · National Cancer Institute, Naples · NCT06509126Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Res
NA · 9 location(s) · Medtronic - MITG · NCT07351071Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Me
Phase 3 · 1 location(s) · Genmab · NCT07702032Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colore
NA · 1 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT07098182D2 vs D3 Lymph Node Dissection for Left Colon Cancer
NA · 1 location(s) · Russian Society of Colorectal Surgeons · NCT04364373Peripheral Autonomic Block (BAP) Plus Transversus Abdominis Plane Block (TAP) for Postoperative Analgesia After Minimall
NA · 1 location(s) · Faculdade de Ciências Médicas de Minas Gerais · NCT07388953Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer
Phase N/A · 4 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06135571A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Parti
Phase 3 · 237 location(s) · Janssen Research & Development, LLC · NCT06662786Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Phase 2 · 1 location(s) · Xinqiao Hospital of Chongqing · NCT06279351Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Me
Phase 2 · 3 location(s) · Sun Yat-sen University · NCT05959356Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer
Phase 3 · 3 location(s) · City Clinical Oncology Hospital No 1 · NCT06226857Robotic Versus Laparoscopy NOSE for Stage I-III Left-sided Colon Cancer
NA · 1 location(s) · National Taiwan University Hospital · NCT05970133Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer
NA · 1 location(s) · Beijing Chao Yang Hospital · NCT05202314Single-Stapled Technique for Colorectal Anastomosis
Phase N/A · 5 location(s) · Umeå University · NCT07417358
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.